FONAR (FONR) Competitors

FONAR (NASDAQ:FONR) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, community ranking, risk, institutional ownership, profitability, valuation, earnings, media sentiment and analyst recommendations.

Do insiders and institutionals hold more shares of FONR or CLPT?

50.6% of FONAR shares are owned by institutional investors. Comparatively, 30.1% of ClearPoint Neuro shares are owned by institutional investors. 1.6% of FONAR shares are owned by company insiders. Comparatively, 7.0% of ClearPoint Neuro shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Is FONR or CLPT more profitable?

FONAR has a net margin of 7.68% compared to ClearPoint Neuro's net margin of -59.64%. FONAR's return on equity of 4.94% beat ClearPoint Neuro's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FONAR	7.68%	4.94%	3.70%
ClearPoint Neuro	-59.64%	-62.10%	-38.39%

Which has stronger valuation & earnings, FONR or CLPT?

FONAR has higher revenue and earnings than ClearPoint Neuro. ClearPoint Neuro is trading at a lower price-to-earnings ratio than FONAR, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FONAR	$103.02M	0.87	$10.57M	$1.25	11.60
ClearPoint Neuro	$32.24M	10.49	-$22.09M	-$0.76	-15.89

Which has more risk and volatility, FONR or CLPT?

FONAR has a beta of 0.99, suggesting that its share price is 1% less volatile than the S&P 500. Comparatively, ClearPoint Neuro has a beta of 0.93, suggesting that its share price is 7% less volatile than the S&P 500.

Does the media favor FONR or CLPT?

In the previous week, FONAR and FONAR both had 5 articles in the media. ClearPoint Neuro's average media sentiment score of 1.19 beat FONAR's score of 0.63 indicating that ClearPoint Neuro is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
FONAR	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ClearPoint Neuro	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community prefer FONR or CLPT?

FONAR received 156 more outperform votes than ClearPoint Neuro when rated by MarketBeat users. However, 86.21% of users gave ClearPoint Neuro an outperform vote while only 74.79% of users gave FONAR an outperform vote.

Company	Underperform	Outperform
FONAR	Outperform Votes 181 74.79%	Underperform Votes 61 25.21%
ClearPoint Neuro	Outperform Votes 25 86.21%	Underperform Votes 4 13.79%

Do analysts prefer FONR or CLPT?

ClearPoint Neuro has a consensus price target of $25.00, suggesting a potential upside of 106.95%. Given ClearPoint Neuro's stronger consensus rating and higher probable upside, analysts plainly believe ClearPoint Neuro is more favorable than FONAR.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FONAR	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
ClearPoint Neuro	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

FONAR beats ClearPoint Neuro on 10 of the 17 factors compared between the two stocks.